BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

715 related articles for article (PubMed ID: 7586356)

  • 1. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov; 92(9):2550-7. PubMed ID: 7586356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
    Bellandi F; Dabizzi RP; Niccoli L; Cantini F; Palchetti R
    G Ital Cardiol; 1996 Apr; 26(4):379-90. PubMed ID: 8707022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence].
    Fera MS; Carunchio A; Burattini M; Mazza A; Coletta C; Galati A; Ceci V
    G Ital Cardiol; 1997 Feb; 27(2):152-63. PubMed ID: 9244718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
    Tendera M; Wnuk-Wojnar AM; Kulakowski P; Malolepszy J; Kozlowski JW; Krzeminska-Pakula M; Szechinski J; Droszcz W; Kawecka-Jaszcz K; Swiatecka G; Ruzyllo W; Graff O
    Am Heart J; 2001 Jul; 142(1):93-8. PubMed ID: 11431663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study].
    Gao X; Zhu J; Yang YM; Li JD; Yang ZM; Liu JH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):151-4. PubMed ID: 17445412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
    Boutaud P; Guillem JP; Maarek-Charbit M; Amiel A; Ciber M; Herpin D; Demange J
    Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
    Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
    Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial.
    Mörike K; Kivistö KT; Schaeffeler E; Jägle C; Igel S; Drescher S; Fux R; Marx C; Hofmann U; Engel C; Wagner F; Delabar U; Meisner C; Bail D; Böhm JO; Gleiter CH; Ziemer G; Rein JG; Hellberg KD; Eichelbaum M; Schwab M
    Clin Pharmacol Ther; 2008 Jul; 84(1):104-10. PubMed ID: 18167502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and the pharmacological treatment: the role of propafenone.
    Sestito A; Molina E
    Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):242-53. PubMed ID: 22428477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T; Abuladze G; Nebieridze M
    Georgian Med News; 2010 Jun; (183):18-21. PubMed ID: 20622270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
    Alboni P; Botto GL; Baldi N; Luzi M; Russo V; Gianfranchi L; Marchi P; Calzolari M; Solano A; Baroffio R; Gaggioli G
    N Engl J Med; 2004 Dec; 351(23):2384-91. PubMed ID: 15575054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL; McCarthy EA; Wilkinson WE
    Ann Intern Med; 1991 Apr; 114(7):539-44. PubMed ID: 2001087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
    Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
    Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.